News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
GREAT POINT PARTNERS LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 10% stake in OPTINOSE, INC. |
| 02/14/2023 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 3.1% stake in Kalvista Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 1.4% stake in 89bio, Inc. |
| 02/14/2023 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 3.4% stake in Precision BioSciences Inc. |
| 02/14/2023 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 7.9% stake in ALPINE IMMUNE SCIENCES, INC. |
| 02/14/2022 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in InflaRx N.V. |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in Abeona Therapeutics Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 4% stake in Geron Corporation |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 1.4% stake in Millendo Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 1.8% stake in Zymeworks Inc. |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in TG Therapeutics, Inc. |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in VYNE Therapeutics Inc. |
| 02/16/2021 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 2.4% stake in Prothena Corporation Public Limited Company |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in Proteostasis Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in Proteostasis Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in Foamix Pharmaceuticals Ltd. |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0.3% stake in Cytokinetics, Incorporated |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 1.5% stake in Zogenix, Inc. |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in Audentes Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 6.8% stake in Menlo Therapeutics Inc. |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in Five Prime Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 1.9% stake in Kura Oncology, Inc. |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 9.8% stake in Millendo Therapeutics, Inc. |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 5.3% stake in Prothena Corporation Public Limited Company |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in Streamline Health Solutions, Inc. |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in Savara Inc. |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in Zafgen, Inc. |
| 02/14/2020 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 0% stake in BioCryst Pharmaceuticals, Inc. |
| 05/14/2019 |
SC 13G/A
| GREAT POINT PARTNERS LLC reports a 2.8% stake in Puma Biotechnology, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|